In addition to the most up-to-date management approaches to tremors and other issues related to Parkinson disease, the conference will cover a vast array of other offerings. Neurology Times will provide daily updates for those attending in person or remotely. Get your quick intro here.
You’ll want to get to bed early on Thursday, because you’ll have a very full week ahead. And even if you can't make #MDSCongress, October 5-9, 2018, get your highlights and Editor's Picks here.
New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
The importance of effective communication and cultural awareness in patient care and outcomes cannot be overstated.
Dr. Abhinav Raina presents his research on the effect of subthalamic nucleus deep brain stimulation on impulsivity in Parkinson disease patients.
Glioblastoma multiforme is the most common and most malignant of all brain tumors. Are things getter better?
An expert presents the results of a phase 2 study on the impact of rituximab on myasthenia gravis.
An expert describes the efficacy of fenfluramine in decreasing seizure frequency associated with this rare syndrome.
A unique case of chronic, low level carbon monoxide poisoning in a car mechanic that resulted in Parkinsonian symptoms.
The presence of REM Behavior Disorder predicted an increased risk of Parkinson disease, Lewy Body dementia, or multisystem atrophy in the largest study ever performed in people with the strange disorder. Details here.